The role of acetylcholine in cocaine addiction

Neuropsychopharmacology

Volumn 33, Issue 8, 2008, Pages 1779-1797

  Williams, Mark J ^a   Adinoff, Bryon ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Acetylcholine; Attention; Cocaine dependence; Executive functioning; Learning and memory; Reward

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; ARECOLINE; ATROPINE; CARBACHOL; COCAINE; DONEPEZIL; ECOPIPAM; FLUMAZENIL; GALANTAMINE; GALLAMINE; MECAMYLAMINE; MUSCARINIC RECEPTOR; NALOXONE; NEOSTIGMINE; NICOTINIC RECEPTOR; OXOTREMORINE; PHYSOSTIGMINE; PIRENZEPINE; QUINPIROLE; RACLOPRIDE; SCOPOLAMINE;

ADAPTATION; AMYGDALOID NUCLEUS; AROUSAL; ASSOCIATION; ATTENTION; AVERSION; BRAIN REGION; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COCAINE DEPENDENCE; COGNITION; CORPUS STRIATUM; DECISION MAKING; DISEASE EXACERBATION; DOSE RESPONSE; DRUG SELF ADMINISTRATION; EXPLICIT MEMORY; HUMAN; INTERNEURON; LEARNING; LIMBIC SYSTEM; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RELAPSE; REVIEW; REWARD; SATIETY; SENSITIZATION; VENTRAL TEGMENTUM;

ACETYLCHOLINE; ADAPTATION, PSYCHOLOGICAL; ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; COGNITION; DISEASE MODELS, ANIMAL; HUMANS; LEARNING; MEMORY; NEOSTRIATUM; PARASYMPATHETIC NERVOUS SYSTEM; REWARD;

EID: 45149123897     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301585     Document Type: Review

References (249)

1. Acquas E, Day JC, Fibiger HC (1994). The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat. Eur J Pharmacol 260: 85-87.
2. Adinoff B (2004). Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 12: 305-320.
3. Adinoff B, Devous MD, Best SM, George MS, Alexander D, Payne K (2001). Limbic responsiveness to procaine in cocaine-addicted subjects. Am J Psychiatry 158: 390-398.
4. Adinoff B, Rilling LM, Williams MJ, Schreffler ER, Schepis TY, Rosvall T et al (in press). Impulsivity, neural deficits, and the addictions: the 'Oops' factor in relapse. J Addict Dis.
5. Adinoff B, Williams MJ, Best SE, Zielinski TA, Harris TS, Schreffler ER et al (2005). Cholinergic receptor systems in cocaine-addicted subjects: alterations in regional cerebral blood flow. Neuropsychopharmacology 30: S84.
6. 3H]SCH23390. J Chem Neuroanat 5: 357-366.
7. Alburges ME, Narang N, Wamsley JK (1993). Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14: 314-323.
8. Alcantara AA, Chen V, Herring BE, Mendenhall JM, Berlanga ML (2003). Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Brain Res 986: 22-29.
9. Aosaki T, Tsubokawa H, Ishida A, Watanabe K, Graybiel AM, Kimura M (1994). Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. J Neurosci 14: 3969-3984.
10. Apicella P (2002). Tonically active neurons in the primate striatum and their role in the processing of information about motivationally relevant events. Eur J Neurosci 16: 2017-2026.
11. Apicella P (2007). Leading tonically active neurons of the striatum from reward detection to context recognition. Trends Neurosci 30: 299-306.
12. Apicella P, Legallet E, Trouche E (1997). Responses of tonically discharging neurons in the monkey striatum to primary rewards delivered during different behavioral states. Exp Brain Res 116: 456-466.
13. Ardila A, Rosselli M, Strumwasser S (1991). Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 57: 73-79.
14. Arnold JC (2005). The role of endocannabinoid transmission in cocaine addiction. Pharmacol Biochem Behav 81: 396-406.
15. Arnold JM, Roberts DC (1997). A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57: 441-447.
16. Balster RL (1991). Drug abuse potential evaluation in animals. Br J Addict 86: 1549-1558.
17. Bardo MT (1998). Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 12: 37-67.
18. Bardo MT, Rowlett JK, Harris MJ (1995). Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19: 39-51.
19. Baxter MG, Chiba AA (1999). Cognitive functions of the basal forebrain. Curr Opin Neurobiol 9: 178-183.
20. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ (1995). Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 37: 247-253.
21. Bechara A, van der Kooy D (1989). The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. J Neurosci 9: 3400-3409.
22. Bechtholt AJ, Mark GP (2002). Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats. Psychopharmacology (Berl) 162: 178-185.
23. Berke JD, Eichenbaum HB (2001). Drug addiction and the hippocampus. Science 294: 1235.
24. Berlanga ML, Olsen CM, Chen V, Ikegami A, Herring BE, Duvauchelle CL et al (2003). Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 120: 1149-1156.
25. Berlanga ML, Simpson TK, Alcantara AA (2005). Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release. J Comp Neurol 492: 34-49.
26. Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369.
27. Bertorelli R, Consolo S (1990). D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J Neurochem 54: 2145-2148.
28. Blokhina EA, Kashkin VA, Zvartau EE, Danysz W, Bespalov AY (2005). Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice. Eur Neuropsychopharmacol 15: 219-225.
29. 3H]acetylcholine release in prenatally cocaine-exposed male and female rats. Prog Neuropsychopharmacol Biol Psychiatry 26: 1339-1348.
30. Bolanos CA, Trksak GH, Glatt SJ, Jackson D (2000). Prenatal cocaine exposure increases serotonergic inhibition of electrically evoked acetylcholine release from rat striatal slices at adulthood. Synapse 36: 1-11.
31. Bonner TI, Buckley NJ, Young AC, Brann MR (1987). Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527-532.
32. Bonsi P, Cuomo D, Ding J, Sciamanna G, Ulrich S, Tscherter A et al (2007). Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 32: 1840-1854.
33. Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL et al (2002). Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26: 376-386.
34. Bosboom JL, Stoffers D, Wolters E (2003). The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease. In: R Horowski, Y Mizuno, CW Olanow, WH Poewe, P Riederer, JA Stoessl, MBH Youdim (eds). Advances in Research on Neurodegeneration, 10(Suppl 65), pp 185-195.
35. Bradberry CW, Barrett-Larimore RL, Jatlow P, Rubino SR (2000). Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys. J Neurosci 20: 3874-3883.
36. Breese CR, Hampson RE, Deadwyler SA (1989). Hippocampal place cells: stereotypy and plasticity. J Neurosci 9: 1097-1111.
37. Browman KE, Badiani A, Robinson TE (1998). The influence of environment on the induction of sensitization to the psychomotor activating effects of intravenous cocaine in rats is dosedependent. Psychopharmacology (Berl) 137: 90-98.
38. Brown EE, Robertson GS, Fibiger HC (1992). Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J Neurosci 12: 4112-4121.
39. Butcher SG, Butcher LLBR (1974). Origin and modulation of acetylcholine activity in the neostriatum. Brain Res 71: 167-171.
40. Caine SB, Koob GF, Parsons LH, Everitt BJ, Schwartz JC, Sokoloff P (1997). D3 receptor test in vitro predicts decreased cocaine self-administration in rats. NeuroReport 8: 2373-2377.
41. Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (2000). Acetylcholine-mediated modulation of striatal function. Trends Neurosci 23: 120-126.
42. Cambridge C (2002). Cambridge Neuropsychological Test Automated Battery Expedio (CANTABExpedio). Cambridge Cognition Limited: Cambridge, England.
43. Camp MC, Mayfield RD, McCracken M, McCracken L, Alcantara AA (2006). Neuroadaptations of Cdk5 in cholinergic interneurons of the nucleus accumbens and prefrontal cortex of inbred alcohol-preferring rats following voluntary alcohol drinking. Alcohol Clin Exp Res 30: 1322-1335.
44. Champtiaux N, Kalivas PW, Bardo MT (2006). Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats. Behav Brain Res 168: 120-126.
45. Chang JY, Sawyer SF, Lee RS, Woodward DJ (1994). Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J Neurosci 14: 1224-1244.
46. Chau DT, Rada P, Kosloff RA, Taylor JL, Hoebel BG (2001). Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test. Neuroscience 104: 791-798.
47. Chen KC, Baxter MG, Rodefer JS (2004). Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting. Eur J Neurosci 20: 1081-1088.
48. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999). Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156: 11-18.
49. Ciccocioppo R, Sanna PP, Weiss F (2001). Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci USA 98: 1976-1981.
50. Clarke PB, Pert A (1985). Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348: 355-358.
51. Colgin LL, Kubota D, Lynch G (2003). Cholinergic plasticity in the hippocampus. Proc Natl Acad Sci USA 100: 2872-2877.
52. Collins SL, Izenwasser S (2004). Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs adult male and female rats. Neuropharmacology 46: 349-362.
53. Consolo S, Caltavuturo C, Colli E, Recchia M, Di Chiara G (1999). Different sensitivity of in vivo acetylcholine transmission to D1 receptor stimulation in shell and core of nucleus accumbens. Neuroscience 89: 1209-1217.
54. Cooper DC, Klipec WD, Fowler MA, Ozkan ED (2006). A role for the subiculum in the brain motivation/reward circuitry. Behav Brain Res 174: 225-231.
55. Coyle JT, Price DL, DeLong MR (1983). Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184-1190.
56. Cragg SJ (2006). Meaningful silences: how dopamine listens to the ACh pause. Trends Neurosci 29: 125-131.
57. Crespo JA, Sturm K, Saria A, Zernig G (2006). Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 26: 6004-6010.
58. Crombag HS, Badiani A, Robinson TE (1996). Signalled versus unsignalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization. Brain Res 722: 227-231.
59. Cummings JL (2000). Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatry 157: 4-15.
60. Dackis CA, O'Brien CP (2001). Cocaine dependence: a disease of the brain's reward centers. J Substance Abuse Treat 21: 111-117.
61. Dalley JW, Laane K, Pena Y, Theobald DE, Everitt BJ, Robbins TW (2005). Attentional and motivational deficits in rats withdrawn from intravenous self-administration of cocaine or heroin. Psychopharmacology (Berl) 182: 579-587.
62. Day J, Fibiger HC (1992). Dopaminergic regulation of cortical acetylcholine release. Synapse 12: 281-286.
63. Day JC, Fibiger HC (1994). Dopaminergic regulation of septohippocampal cholinergic neurons. J Neurochem 63: 2086-2092.
64. de la Garza R, Johanson CE (1982). Effects of haloperidol and physostigmine on self-administration of local anesthetics. Pharmacol Biochem Behav 17: 1295-1299.
65. Deng P, Zhang Y, Xu ZC (2007). Involvement of I(h) in dopamine modulation of tonic firing in striatal cholinergic interneurons. J Neurosci 27: 3148-3156.
66. Desai RI, Terry P (2003). Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice. Psychopharmacology (Berl) 166: 111-119.
67. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C et al (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47(Suppl 1): 227-241.
68. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S et al (1999). Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann NY Acad Sci 877: 461-485.
69. 18F] fluoroepibatidine. J Neurochem 74: 1514-1521.
70. Drukarch B, Schepens E, Stoof JC (1990). Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway. Neuroscience 37: 1-9.
71. Ellis JM (2005). Cholinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc 105: 145-158.
72. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW (1999). Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann NY Acad Sci 877: 412-438.
73. Everitt BJ, Robbins TW (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489.
74. Fink-Jensen A, Fedorova I, Wortwein G, Woldbye DP, Rasmussen T, Thomsen M et al (2003). Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 74: 91-96.
75. Flynn DD, Vaishnav AA, Mash DC (1992). Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Mol Pharmacol 41: 736-742.
76. Forster GL, Yeomans JS, Takeuchi J, Blaha CD (2002). M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 22: RC190.
77. Furey ML, Pietrini P, Haxby JV (2000). Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290: 2315-2319.
78. Gardner EL (2000). What we have learned about addiction from animal models of drug self-administration. Am J Addict 9: 285-313.
79. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003). It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26: 184-192.
80. Goldstein RZ, Volkow ND (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642-1652.
81. Gorelick DA, Gardner EL, Xi ZX (2004). Agents in development for the management of cocaine abuse. Drugs 64: 1547-1573.
82. Graham AJ, Martin-Ruiz CM, Teaktong T, Ray MA, Court JA (2002). Human brain nicotinic receptors, their distribution and participation in neuropsychiatric disorders. Curr Drug Targets CNS Neurol Disord 1: 387-397.
83. Grecksch G, Ott T, Matthies H (1978). Influence of post-training intrahippocampally applied oxotremorine on the consolidation of a brightness discrimination. Pharmacol Biochem Behav 8: 215-218.
84. Grillner P, Berretta N, Bernardi G, Svensson TH, Mercuri NB (2000). Muscarinic receptors depress GABAergic synaptic transmission in rat midbrain dopamine neurons. Neuroscience 96: 299-307.
85. Harsing Jr LG, Zigmond MJ (1998). Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Brain Res Bull 45: 607-613.
86. Hasselmo ME, Fehlau BP (2001). Differences in time course of ACh and GABA modulation of excitatory synaptic potentials in slices of rat hippocampus. J Neurophysiol 86: 1792-1802.
87. Hasselmo ME, Hay J, Ilyn M, Gorchetchnikov A (2002). Neuromodulation, theta rhythm and rat spatial navigation. Neural Netw 15: 689-707.
88. Heidbreder CA, Shippenberg TS (1996). Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse 24: 182-192.
89. Heidbreder CA, Thompson AC, Shippenberg TS (1996). Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 278: 490-502.
90. Hikida T, Kaneko S, Isobe T, Kitabatake Y, Watanabe D, Pastan I et al (2001). Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proc Natl Acad Sci USA 98: 13351-13354.
91. Hikida T, Kitabatake Y, Pastan I, Nakanishi S (2003). Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci USA 100: 6169-6173.
92. Hirsh R, Davis RE, Holt L (1979). Fornix - thalamus fibers, motivational states, and contextual retrieval. Exp Neurol 65: 373-390.
93. Horner B, Scheibe K, Stine S (1996). Cocaine abuse and attention-deficit hyperactivity disorder: implications of adult symptomatology. Psychol Addict Behav 10: 55-60.
94. Hyman SE (2005). Addiction: a disease of learning and memory. Am J Psychiatry 162: 1414-1422.
95. Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598.
96. Ikemoto S, Wise RA (2002). Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J Neurosci 22: 9895-9904.
97. Imperato A, Obinu MC, Gessa GL (1993a). Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur J Pharmacol 238: 377-381.
98. Imperato A, Obinu MC, Gessa GL (1993b). Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus. Brain Res 618: 341-345.
99. Imperato A, Obinu MC, Mascia MS, Casu MA, Zocchi A, Cabib S et al (1996). Strain-dependent effects of dopamine agonists on acetylcholine release in the hippocampus: an in vivo study in mice. Neuroscience 70: 653-660.
100. Ince E, Ciliax BJ, Levey AI (1997). Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Synapse 27: 357-366.
101. Itzhak Y, Martin JL (2000). Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice. Psychopharmacology (Berl) 152: 216-223.
102. Jacobs EH, Smit AB, de Vries TJ, Schoffelmeer AN (2003). Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol Sci 24: 566-573.
103. Jaffard R, Destrade C, Soumireu-Mourat B, Durkin T, Ebel A (1980). Changes in hippocampal cholinergic activity following learning in mice. Neurosci Lett 19: 349-352.
104. Janowsky DS, Overstreet DH (2000). The role of acetylcholine mechanisms in affective disorders. In: JF Mendo-Woodruff (ed). Psychopharmacology: The Fourth Generation of Progress (Retrieved July 15, 2007 from http://WWW.acnp.org/g4/GN401000095/Default.htm).
105. Jovanovski D, Erb S, Zakzanis KK (2005). Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 27: 189-204.
106. Kalivas PW (1995). Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 37: 95-100.
107. Kalivas PW (2004). Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4: 23-29.
108. Kalivas PW, Pierce RC, Cornish J, Sorg BA (1998). A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol 12: 49-53.
109. Karpen JW, Hess GP (1986). Cocaine, phencyclidine, and procaine inhibition of the acetylcholine receptor: characterization of the binding site by stopped-flow measurements of receptor-controlled ion flux in membrane vesicles. Biochemistry (Mosc) 25: 1777-1785.
110. Katz JL, Higgins ST (2003). The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 168: 21-30.
111. Kauer JA (2003). Addictive drugs and stress trigger a common change at VTA synapses. Neuron 37: 549-550.
112. Kelley AE, Berridge KC (2002). The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22: 3306-3311.
113. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F et al (2001). Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58: 334-341.
114. Kimura M, Yamada H, Matsumoto N (2003). Tonically active neurons in the striatum encode motivational contexts of action. Brain Dev 25(Suppl 1): S20-S23.
115. Kish SJ, Kalasinsky KS, Furukawa Y, Guttman M, Ang L, Li L et al (1999). Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Mol Psychiatry 4: 26-32.
116. Kitabatake Y, Hikida T, Watanabe D, Pastan I, Nakanishi S (2003). Impairment of reward-related learning by cholinergic cell ablation in the striatum. Proc Natl Acad Sci USA 100: 7965-7970.
117. Kleber HD (2003). Pharmacologic treatments for heroin and cocaine dependence. Am J Addict 12(Suppl 2): S5-S18.
118. Klink R, de Kerchove d'Exaerde A, Zoli M, Changeux JP (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21: 1452-1463.
119. Koob GF (2000). Animal models of drug addiction. In: Psychopharmacology: The Fourth Generation of Progress (Retrieved July 15, 2007 from http://WWW.acnp.org/g4/GN401000072/Default.htm).
120. Koos T, Tepper JM (2002). Dual cholinergic control of fast-spiking interneurons in the neostriatum. J Neurosci 22: 529-535.
121. Kosten TR, George TP, Kosten TA (2002). The potential of dopamine agonists in drug addiction. Expert Opin Investig Drugs 11: 491-499.
122. Kupfermann I, Kandel ER, Iversen S (2000). Motivational and Addictive States. McGraw-Hill: New York.
123. Lautin A (2001). The Limbic Brain. Kluwer Academics/Plenum Publishers: New York.
124. Lecca D, Cacciapaglia F, Valentini V, Acquas E, Di Chiara G (2007). Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology (Berl) 191: 653-667.
125. Legault G, Smith CT, Beninger RJ (2006). Post-training intrastriatal scopolamine or flupenthixol impairs radial maze learning in rats. Behav Brain Res 170: 148-155.
126. Levey AI (1996). Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc Natl Acad Sci USA 93: 13541-13546.
127. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR (1991). Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11: 3218-3226.
128. Lewis PR, Shute CC (1967). The cholinergic limbic system: projections to hippocampal formation, medial cortex, nuclei of the ascending cholinergic reticular system, and the subfornical organ and supra-optic crest. Brain 90: 521-540.
129. Lipton JW, Olsen RW, Ellison GD (1995). Length of continuous cocaine exposure determines the persistence of muscarinic and benzodiazepine receptor alterations. Brain Res 676: 378-385.
130. Lucki I (1997). The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8: 523-532.
131. Ma Y, Kiesewetter DO, Jagoda EM, Huang BX, Eckelman WC (2002). Identification of metabolites of fluorine-18-labeled M2 muscarinic receptor agonist, 3-(3-[(3-fluoropropyl)thio]-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro- 1-me thylpyridine, produced by human and rat hepatocytes. J Chromatogr B Anal Technol Biomed Life Sci 766: 319-329.
132. Macedo DS, Correia EE, Vasconcelos SM, Aguiar LM, Viana GS, Sousa FC (2004). Cocaine treatment causes early and longlasting changes in muscarinic and dopaminergic receptors. Cell Mol Neurobiol 24: 129-136.
133. 11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats. Neuropsychopharmacology 19: 146-153.
134. Mark GP, Blander DS, Hoebel BG (1991). A conditioned stimulus decreases extracellular dopamine in the nucleus accumbens after the development of a learned taste aversion. Brain Res 551: 308-310.
135. Mark GP, Hajnal A, Kinney AE, Keys AS (1999). Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology (Berl) 143: 47-53.
136. Mark GP, Rada P, Pothos E, Hoebel BG (1992). Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum, and hippocampus of freely behaving rats. J Neurochem 58: 2269-2274.
137. Mark GP, Weinberg JB, Rada PV, Hoebel BG (1995). Extracellular acetylcholine is increased in the nucleus accumbens following the presentation of an aversively conditioned taste stimulus. Brain Res 688: 184-188.
138. Mayfield RD, Larson G, Zahniser NR (1992). Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res 573: 331-335.
139. McGaughy J, Dalley JW, Morrison CH, Everitt BJ, Robbins TW (2002). Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22: 1905-1913.
140. McIntyre CK, Ragozzino ME, Gold PE (1998). Intra-amygdala infusions of scopolamine impair performance on a conditioned place preference task but not a spatial radial maze task. Behav Brain Res 95: 219-226.
141. McKinney M, Coyle JT, Hedreen JC (1983). Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 217: 103-121.
142. Meil WM, See RE (1997). Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res 87: 139-148.
143. Mena-Segovia JRH, Magill PJ, Bolam JP (2005). The Pudunculopontine Nucleus: Towards a Functional Integration with the Basal Ganglia. Springer Science and Business Media: New York.
144. Mesulam MM (1996). The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog Brain Res 109: 285-297.
145. Mihailescu S, Drucker-Colin R (2000). Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res 31: 131-144.
146. Miliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D (1986). The curve-shift paradigm in self-stimulation. Physiol Behav 37: 85-91.
147. Morris G, Arkadir D, Nevet A, Vaadia E, Bergman H (2004). Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 43: 133-143.
148. Muir JL, Dunnett SB, Robbins TW, Everitt BJ (1992). Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89: 611-622.
149. Muir JL, Everitt BJ, Robbins TW (1995). Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology (Berl) 118: 82-92.
150. Muller CP, Carey RJ, Huston JP (2003). Serotonin as an important mediator of cocaine's behavioral effects. Drugs Today (Barc) 39: 497-511.
151. Museo E, Wise RA (1994). Place preference conditioning with ventral tegmental injections of cytisine. Life Sci 55: 1179-1186.
152. Niu L, Abood LG, Hess GP (1995). Cocaine: mechanism of inhibition of a muscle acetylcholine receptor studied by a laser-pulse photolysis technique. Proc Natl Acad Sci USA 92: 12008-12012.
153. O'Brien CP, Gardner EL (2005). Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol Ther 108: 18-58.
154. Olds J, Milner P (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 47: 419-427.
155. Olmstead MC, Franklin KB (1993). Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test. Neuroscience 57: 411-418.
156. Palencia CA, Ragozzino ME (2006). The effect of N-methyl- D-aspartate receptor blockade on acetylcholine efflux in the dorsomedial striatum during response reversal learning. Neuroscience 143: 671-678.
157. Papez J (1995). A proposed mechanism of emotion. J Neuropsychiatry Clin Neurosci 7: 103-112.
158. Parasuraman R (1998). The Attentive Brain. MIT Press: Cambridge, MA.
159. Pavlov IP (1927). Conditioned Reflexes. Routledge and Kegan Paul: London.
160. Pepeu G, Giovannini MG (2004). Changes in acetylcholine extracellular levels during cognitive processes. Learn Mem 11: 21-27.
161. Pfister M, Boix F, Huston JP, Schwarting RK (1994). Different effects of scopolamine on extracellular acetylcholine levels in neostriatum and nucleus accumbens measured in vivo: possible interaction with aversive stimulation. J Neural Transm Gen Sect 97: 13-25.
162. Pisani A, Bonsi P, Catania MV, Giuffrida R, Morari M, Marti M et al (2002). Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons. J Neurosci 22: 6176-6185.
163. Pisani A, Bonsi P, Picconi B, Tolu M, Giacomini P, Scarnati E (2001). Role of tonically-active neurons in the control of striatal function: cellular mechanisms and behavioral correlates. Prog Neuropsychopharmacol Biol Psychiatry 25: 211-230.
164. Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391.
165. Power AE, McIntyre CK, Litmanovich A, McGaugh JL (2003). Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors. Behav Pharmacol 14: 207-213.
166. Pratt WE, Kelley AE (2004). Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors. Behav Neurosci 118: 730-739.
167. Pratt WE, Kelley AE (2005). Striatal muscarinic receptor antagonism reduces 24-h food intake in association with decreased preproenkephalin gene expression. Eur J Neurosci 22: 3229-3240.
168. Quirion R, Aubert I, Lapchak PA, Schaum RP, Teolis S, Gauthier S et al (1989). Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. Trends Pharmacol Sci (Suppl): 80-84.
169. Rada P, Avena NM, Hoebel BG (2005). Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 134: 737-744.
170. Rada P, Colasante C, Skirzewski M, Hernandez L, Hoebel B (2006). Behavioral depression in the swim test causes a biphasic, longlasting change in accumbens acetylcholine release, with partial compensation by acetylcholinesterase and muscarinic-1 receptors. Neuroscience 141: 67-76.
171. Rada P, Hoebel BG (2005). Acetylcholine in the accumbens is decreased by diazepam and increased by benzodiazepine withdrawal: a possible mechanism for dependency. Eur J Pharmacol 508: 131-138.
172. Rada P, Jensen K, Hoebel BG (2001). Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology (Berl) 157: 105-110.
173. Rada P, Johnson DF, Lewis MJ, Hoebel BG (2004). In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal. Pharmacol Biochem Behav 79: 599-605.
174. Rada P, Pothos E, Mark GP, Hoebel BG (1991). Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res 561: 354-356.
175. Rada PV, Hoebel BG (2000). Supraadditive effect of d-fenfluramine plus phentermine on extracellular acetylcholine in the nucleus accumbens: possible mechanism for inhibition of excessive feeding and drug abuse. Pharmacol Biochem Behav 65: 369-373.
176. Rada PV, Hoebel BG (2001). Aversive hypothalamic stimulation releases acetylcholine in the nucleus accumbens, and stimulation-escape decreases it. Brain Res 888: 60-65.
177. Ragozzino ME, Choi D (2004). Dynamic changes in acetylcholine output in the medial striatum during place reversal learning. Learn Mem 11: 70-77.
178. Ragozzino ME, Jih J, Tzavos A (2002). Involvement of the dorsomedial striatum in behavioral flexibility: role of muscarinic cholinergic receptors. Brain Res 953: 205-214.
179. Rasch BH, Born J, Gais S (2006). Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation. J Cogn Neurosci 18: 793-802.
180. Redgrave P, Horrell RI (1976). Potentiation of central reward by localised perfusion of acetylcholine and 5-hydroxytryptamine. Nature 262: 305-307.
181. Reid MS, Mickalian JD, Delucchi KL, Berger SP (1999). A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology 20: 297-307.
182. Reid MS, Mickalian JD, Delucchi KL, Hall SM, Berger SP (1998). An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend 49: 95-104.
183. Rilling LM, Adinoff B (2007). Cognitive dysfunction in cocaine abuse: evidence for impairments in impulse control and decision-making. In: Pizzoli LA (ed). Cocaine and Heroin Abuse Research. Nova Science Publishers: Hauppauge, NY. pp 81-95.
184. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380.
185. Roberts DC (2005). Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction. Physiol Behav 86: 18-20.
186. Robinson SE, Hambrecht KL (1988). The effect of cocaine on hippocampal cholinergic and noradrenergic metabolism. Brain Res 457: 383-385.
187. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
188. Robinson TE, Browman KE, Crombag HS, Badiani A (1998). Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehav Rev 22: 347-354.
189. Roediger III HL (1990). Implicit memory. Retention without remembering. Am Psychol 45: 1043-1056.
190. Rosselli M, Ardila A, Lubomski M, Murray S, King K (2001). Personality profile and neuropsychological test performance in chronic cocaine-abusers. Int J Neurosci 110: 55-72.
191. Sanchis-Segura C, Spanagel R (2006). Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11: 2-38.
192. Santiago MP, Potter LT (2001). Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons. Brain Res 894: 12-20.
193. Sarter M, Bruno JP, Givens B (2003). Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory? Neurobiol Learn Mem 80: 245-256.
194. Sarter M, Bruno JP, Turchi J (1999). Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann NY Acad Sci 877: 368-382.
195. Schacter DL (1992). Implicit knowledge: new perspectives on unconscious processes. Proc Natl Acad Sci USA 89: 11113-11117.
196. Schechter MD, Calcagnetti DJ (1993). Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci Biobehav Rev 17: 21-41.
197. Schindler CW, Panlilio LV, Goldberg SR (2002). Second-order schedules of drug self-administration in animals. Psychopharmacology (Berl) 163: 327-344.
198. Schoffelmeer AN, De Vries TJ, Wardeh G, van de Ven HW, Vanderschuren LJ (2002). Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 22: 3269-3276.
199. Schroeder JP, Packard MG (2004). Facilitation of memory for extinction of drug-induced conditioned reward: role of amygdala and acetylcholine. Learn Mem 11: 641-647.
200. See RE (2005). Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 526: 140-146.
201. See RE, McLaughlin J, Fuchs RA (2003). Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats. Neuroscience 117: 477-483.
202. Seeger T, Fedorova I, Zheng F, Miyakawa T, Koustova E, Gomeza J et al (2004). M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 24: 10117-10127.
203. Self DW (2004). Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47(Suppl 1): 242-255.
204. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3-20.
205. Sharkey J, Ritz MC, Schenden JA, Hanson RC, Kuhar MJ (1988). Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246: 1048-1052.
206. Sharp PE, McNaughton BL, Barnes CA (1985). Enhancement of hippocampal field potentials in rats exposed to a novel, complex environment. Brain Res 339: 361-365.
207. Shizgal P, Fulton S, Woodside B (2001). Brain reward circuitry and the regulation of energy balance. Int J Obes Relat Metab Disord 25(Suppl 5): S17-S21.
208. Siegal D, Erickson J, Varoqui H, Ang L, Kalasinsky KS, Peretti FJ et al (2004). Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse 52: 223-232.
209. Singh HK, Ott T, Matthies H (1974). Effect of intrahippocampal injection of atropine on different phases of a learning experiment. Psychopharmacologia 38: 247-258.
210. Smelson DA, Roy A, Santana S, Engelhart C (1999). Neuropsychological deficits in withdrawn cocaine-dependent males. Am J Drug Alcohol Abuse 25: 377-381.
211. Smith JE, Co C, Yin X, Sizemore GM, Liguori A, Johnson III WE et al (2004a). Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 27: 841-850.
212. Smith JE, Vaughn TC, Co C (2004b). Acetylcholine turnover rates in rat brain regions during cocaine self-administration. J Neurochem 88: 502-512.
213. Sousa FC, Gomes PB, Macedo DS, Marinho MM, Viana GS (1999). Early withdrawal from repeated cocaine administration upregulates muscarinic and dopaminergic D2-like receptors in rat neostriatum. Pharmacol Biochem Behav 62: 15-20.
214. Stewart J, Vezina P (1988). A comparison of the effects of intraaccumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res 457: 287-294.
215. Stolerman IP, Shoaib M (1991). The neurobiology of tobacco addiction. Trends Pharmacol Sci 12: 467-473.
216. Stoof JC, Russchen FT, Verheijden PF, Hoogland PV (1987). A comparative study of the dopamine-acetylcholine interaction in telencephalic structures of the rat and of a reptile, the lizard Gekko gecko. Brain Res 404: 273-281.
217. Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM et al (1993). Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 5: 419-427.
218. Sugita S, Uchimura N, Jiang ZG, North RA (1991). Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain. Proc Natl Acad Sci USA 88: 2608-2611.
219. Suzuki T, Miura M, Nishimura K, Aosaki T (2001). Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons. J Neurosci 21: 6492-6501.
220. Swanson KL, Albuquerque EX (1987). Nicotinic acetylcholine receptor ion channel blockade by cocaine: the mechanism of synaptic action. J Pharmacol Exp Ther 243: 1202-1210.
221. Tessari M, Valerio E, Chiamulera C, Beardsley PM (1995). Nicotine reinforcement in rats with histories of cocaine self-administration. Psychopharmacology (Berl) 121: 282-283.
222. Thomsen M, Woldbye DP, Wortwein G, Fink-Jensen A, Wess J, Caine SB (2005). Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J Neurosci 25: 8141-8149.
223. Tisch S, Silberstein P, Limousin-Dowsey P, Jahanshahi M (2004). The basal ganglia: anatomy, physiology, and pharmacology. Psychiatr Clin N Am 27: 757-799.
224. Tulving E, Schacter DL (1990). Priming and human memory systems. Science 247: 301-306.
225. van der Zee EA, Luiten PG (1999). Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory. Prog Neurobiol 58: 409-471.
226. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN (1999). A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci 19: 9579-9586.
227. Volkow ND, Ding YS, Fowler JS, Gatley SJ (2001). Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia. Biol Psychiatry 49: 211-220.
228. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ et al (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169-177.
229. Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM (2004). Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27: 468-474.
230. Weiner DM, Levey AI, Brann MR (1990). Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87: 7050-7054.
231. Wess J (1993). Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol Sci 14: 308-313.
232. White NM (1996). Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91: 921-949.
233. Wilson JM, Carroll ME, Lac ST, DiStefano LM, Kish SJ (1994). Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine. Neurosci Lett 180: 29-32.
234. Wilson MC, Schuster CR (1973). Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav 1: 643-649.
235. Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ et al (2005). A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100(Suppl 1): 68-77.
236. Wise RA (1996). Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19: 319-340.
237. Wise RA, Rompre PP (1989). Brain dopamine and reward. Annu Rev Psychol 40: 191-225.
238. Wolf ME (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54: 679-720.
239. Wyvell CL, Berridge KC (2000). Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward 'wanting' without enhanced 'liking' or response reinforcement. J Neurosci 20: 8122-8130.
240. Yeomans J, Baptista M (1997). Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57: 915-921.
241. Yeomans J, Forster G, Blaha C (2001). M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci 68: 2449-2456.
242. Yeomans JS, Kofman O, McFarlane V (1985). Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res 329: 19-26.
243. Zanetti L, de Kerchove D'Exaerde A, Zanardi A, Changeux JP, Picciotto MR, Zoli M (2006). Inhibition of both alpha7* and beta2* nicotinic acetylcholine receptors is necessary to prevent development of sensitization to cocaine-elicited increases in extracellular dopamine levels in the ventral striatum. Psychopharmacology (Berl) 187: 181-188.
244. Zeigler S, Lipton J, Toga A, Ellison G (1991). Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res 552: 27-35.
245. Zhang W, Yamada M, Gomeza J, Basile AS, Wess J (2002). Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J Neurosci 22: 6347-6352.
246. Zhou FM, Wilson C, Dani JA (2003). Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 9: 23-36.
247. Zhou FM, Wilson CJ, Dani JA (2002). Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 53: 590-605.
248. Zocchi A, Pert A (1994). Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output. Psychopharmacology (Berl) 115: 297-304.
249. 11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. J Cereb Blood Flow Metab 18: 619-631.